Mark E Anderson

Mark E Anderson

Johns Hopkins University

H-index: 86

North America-United States

About Mark E Anderson

Mark E Anderson, With an exceptional h-index of 86 and a recent h-index of 46 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of CaMKII, mitochondria, heart disease, asthma, oxidant stress.

His recent articles reflect a diverse array of research interests and contributions to the field:

HCN channels sense temperature and determine heart rate responses to heat

CaMKII as a therapeutic target in cardiovascular disease

An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor

Genome-wide CRISPR screen reveals genetic modifiers of Ca 2+-mediated cell death

Mitochondrial CaMKII as a Novel Regulator of Cardiometabolic Dysfunction

Genetic modulation of protein O-GlcNAcylation affects Atrial Fibrillation susceptibility

CRISPR Editing Takes Aim at Ischemia/Reperfusion Injury

CaMKII and reactive oxygen species contribute to early reperfusion arrhythmias, but oxidation of CaMKIIδ at methionines 281/282 is not a determining factor

Mark E Anderson Information

University

Position

___

Citations(all)

23857

Citations(since 2020)

7588

Cited By

18627

hIndex(all)

86

hIndex(since 2020)

46

i10Index(all)

197

i10Index(since 2020)

148

Email

University Profile Page

Johns Hopkins University

Google Scholar

View Google Scholar Profile

Mark E Anderson Skills & Research Interests

CaMKII

mitochondria

heart disease

asthma

oxidant stress

Top articles of Mark E Anderson

Title

Journal

Author(s)

Publication Date

HCN channels sense temperature and determine heart rate responses to heat

bioRxiv

Yuejin Wu

Qinchuan Wang

Jonathan Granger

Oscar Reyes Gaido

Eric Nunez Aguilar

...

2023/9/3

CaMKII as a therapeutic target in cardiovascular disease

Oscar E Reyes Gaido

Lubika J Nkashama

Kate L Schole

Qinchuan Wang

Priya Umapathi

...

2023/1/20

An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor

Science translational medicine

Oscar E Reyes Gaido

Nikoleta Pavlaki

Jonathan M Granger

Olurotimi O Mesubi

Bian Liu

...

2023/6/21

Genome-wide CRISPR screen reveals genetic modifiers of Ca 2+-mediated cell death

bioRxiv

Oscar E Reyes Gaido

Kate L Schole

Mark E Anderson

Elizabeth D Luczak

2023/1/14

Mitochondrial CaMKII as a Novel Regulator of Cardiometabolic Dysfunction

Kimberly Ferrero

Jonathan Granger

Robert Cole

Brian Foster

David Kass

...

2023/6/1

Genetic modulation of protein O-GlcNAcylation affects Atrial Fibrillation susceptibility

Journal of Biological Chemistry

Olurotimi Mesubi

Jonathan Granger

Pauline Nguyen

David Vocadlo

Natasha Zachara

...

2023/1/1

CRISPR Editing Takes Aim at Ischemia/Reperfusion Injury

JAMA cardiology

Oscar E Reyes Gaido

Mark E Anderson

2023/6/1

CaMKII and reactive oxygen species contribute to early reperfusion arrhythmias, but oxidation of CaMKIIδ at methionines 281/282 is not a determining factor

Journal of Molecular and Cellular Cardiology

Marie Haugsten Hansen

Mani Sadredini

Almira Hasic

Mark E Anderson

Ivar Sjaastad

...

2023/2/1

Oxidative stress–induced autonomous activation of the calcium/calmodulin-dependent kinase II involves disulfide formation in the regulatory domain

Journal of Biological Chemistry

Nathália Rocco-Machado

Lo Lai

Geumsoo Kim

Yi He

Elizabeth D Luczak

...

2022/11/1

Myocardial ATP depletion detected noninvasively predicts sudden cardiac death risk in patients with heart failure

JCI insight

T Jake Samuel

Shenghan Lai

Michael Schär

Katherine C Wu

Angela M Steinberg

...

2022/6/6

The effects of genetic ablation of CaMKII oxidation on early ischemia-reperfusion arrhythmias in langendorff-perfused hearts

Cardiovascular Research

M Haugsten Hansen

M Sadredini

A Hasic

ME Anderson

I Sjaastad

...

2022/6/1

Heart Failure and Atrial Fibrillation—Chicken or Egg?

Olurotimi O Mesubi

Mark E Anderson

2022/4/1

The intersection of O-GlcNAc and YAP–A novel molecular axis in heart failure

Journal of Molecular and Cellular Cardiology

Priya Umapathi

Mark Anderson

Natasha Zachara

2022/12/31

Sustainable geoscience in UK HE: evidencing transition through the analysis of student-led project topics.

Jen Roberts

Christopher Jackson

Claire Bond

Mark Anderson

Natasha Dowey

...

2022/1/5

Novel CaMKII biosensor enables identification of potent CaMKII inhibitors

Journal of Molecular and Cellular Cardiology

Oscar Reyes Gaido

Lubika Nkashama

Elizabeth Luczak

Mark Anderson

2022/12/31

Oxidized CaMKII and O-GlcNAcylation cause increased atrial fibrillation in diabetic mice by distinct mechanisms

The Journal of clinical investigation

Olurotimi O Mesubi

Adam G Rokita

Neha Abrol

Yuejin Wu

Biyi Chen

...

2021/1/19

CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1

EP Europace

M Sadredini

R Manotheepan

M Haugsten Hansen

M Frisk

WE Louch

...

2021/5/1

The Role of Oxidized CaMKII in Early Ischemia-Reperfusion Triggered Ventricular Arrhythmias

Circulation

Marie Haugsten Hansen

Mani Sadredini

Almira Hasic

Mark E Anderson

Ivar Sjaastad

...

2021/11/16

Totally Rad? The Long and Winding Road to Understanding CaV1.2 Regulation

Mark E Anderson

2021/1/8

Dysregulation of cardiac CaMKII pathway is increased in aging and chronic inflammation

The FASEB Journal

Ninoshka Mendonca

Shizhang Ling

Diahida Bedja

Ruth Marx

Yuqiong Wu

...

2021/5

See List of Professors in Mark E Anderson University(Johns Hopkins University)